Effect of concurrent acute infection with hepatitis C virus on acute hepatitis B virus infection

BMJ. 1993 Oct 30;307(6912):1095-7. doi: 10.1136/bmj.307.6912.1095.

Abstract

Objective: To investigate the possible interference with acute hepatitis B virus infection by co-infection with hepatitis C virus.

Design: Analysis of stored sera collected for transfusion transmitted viruses study in 1970s.

Setting: Four major medical centres in the United States.

Patients: 12 recipients of blood infected with hepatitis B virus.

Main outcome measures: In 1970s, presence of antibodies in hepatitis B virus and raised serum alanine aminotransferase concentration; detection of antibodies to hepatitis C virus with new enzyme linked immunoassays.

Results: Five of the 12 patients were coinfected with hepatitis C virus. Hepatitis B surface antigen was first detected at day 59 in patients infected with hepatitis B virus alone and at day 97 in those coinfected with hepatitis C virus (p = 0.01); median durations of antigenaemia were 83 and 21 days respectively (p = 0.05), and the antigen concentration was lower in the coinfected patients. Alanine aminotransferase patterns were uniphasic when hepatitis B virus infection occurred alone (range 479-2465 IU/l) and biphasic in patients with combined acute infection (no value > 380 IU/l; p = 0.0025). Four coinfected recipients developed chronic hepatitis C virus infection. The fifth patient was followed for only four months.

Conclusions: Acute coinfection with hepatitis C virus and hepatitis B virus inhibits hepatitis B virus infection in humans, and onset of hepatitis B may reduce the severity of hepatitis C virus infection but not frequency of chronicity. Alanine aminotransferase concentration showed a biphasic pattern in dual infection.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Acute Disease
  • Alanine Transaminase / metabolism
  • Hepatitis B / complications*
  • Hepatitis B / enzymology
  • Hepatitis B / immunology
  • Hepatitis B Core Antigens / analysis
  • Hepatitis B Surface Antigens / analysis
  • Hepatitis C / complications*
  • Hepatitis C / enzymology
  • Hepatitis C / immunology
  • Humans

Substances

  • Hepatitis B Core Antigens
  • Hepatitis B Surface Antigens
  • Alanine Transaminase